首页> 外文期刊>The Journal of Urology >Re: Accuracy of PCA3 Measurement in Predicting Short-Term Biopsy Progression in an Active Surveillance Program J. J. Tosoian, S. Loeb, A. Kettermann, P. Landis, D. J. Elliot, J. I. Epstein, A. W. Partin, H. B. Carter and L. J. Sokoll J Urol 2010; 183: 534-538.
【24h】

Re: Accuracy of PCA3 Measurement in Predicting Short-Term Biopsy Progression in an Active Surveillance Program J. J. Tosoian, S. Loeb, A. Kettermann, P. Landis, D. J. Elliot, J. I. Epstein, A. W. Partin, H. B. Carter and L. J. Sokoll J Urol 2010; 183: 534-538.

机译:回复:在主动监测计划中预测短期活检进展中PCA3测量的准确性JJ Tosoian,S。Loeb,A。Kettermann,P.Landis,DJ Elliot,JI Epstein,AW Partin,HB Carter和LJ Sokoll J Urol 2010 ; 183:534-538。

获取原文
获取原文并翻译 | 示例
       

摘要

To the Editor: We read this article with great interest as the authors assessed the relationship of PCA3 and prostate biopsy results in a considerable number of men (294) participating in a surveillance program for prostate cancer (PCa). ROC analysis revealed that PCA3 alone could not be used to identify men with prostate cancer progression.
机译:致编辑:我们非常感兴趣地阅读了这篇文章,因为作者评估了PCA3与前列腺穿刺活检结果之间的关系,其中相当多的男性(294)参与了前列腺癌(PCa)监视程序。 ROC分析显示,单独PCA3不能用于鉴定患有前列腺癌进展的男性。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号